April 25, 2026 CVS disputes Planned Parenthood's ‘strategic partnership’ claim as report language changes; critics push back CVS disputes Planned Parenthood's claim of a "strategic partnership" on abortion pill access after the organization quietly changed its report language online.
April 22, 2026 Natural hormone may reduce obesity without cutting calories, scientists say Oklahoma researchers found the hormone FGF21 targets the same brain region as GLP-1 drugs, but works by boosting metabolic rate instead of cutting appetite.
April 16, 2026 Peptides may soon be easier to get amid RFK Jr.'s push, but experts warn of risks The FDA is reportedly set to discuss easing peptide restrictions at an anticipated July meeting, as RFK Jr. advocates for making the treatments more accessible.
April 16, 2026 This could be why your weight-loss medication isn’t delivering results A study in Nature found a specific genetic variant that may boost the effectiveness of GLP-1 weight-loss drugs like semaglutide and tirzepatide.
April 14, 2026 Popular weight-loss medications linked to hidden side effects, study finds A new study analyzing Reddit posts found that GLP-1 users reported side effects like fatigue, chills and menstrual irregularities not seen in clinical trials.
April 10, 2026 Divorce boom may follow use of Ozempic and other GLP-1 drugs, experts warn Research suggests GLP-1 drugs like Ozempic and Wegovy could double divorce risk, mirroring trends seen in bariatric surgery patients, experts say.
April 8, 2026 California fraud concerns ramp up as man pleads guilty to massive scheme using taxpayers as his 'piggy bank' Paul Randall, 66, pleads guilty to wire fraud in a scheme that authorities say defrauded Medi-Cal out of more than $178 million in taxpayer funds.
April 3, 2026 Breakthrough ALS study launches as drug aims to slow disease progression The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.
April 2, 2026 New weight-loss pill hits the market, promising 'greater flexibility' FDA approves Foundayo, a once-daily weight loss pill by Lilly. Clinical trials showed adults lost an average of 27.3 pounds on the highest dose, although there are side effects.
April 1, 2026 Should you microdose Ozempic? Experts are split on risks vs benefits Microdosing GLP-1 drugs is trending on social media and supported by some doctors, but experts warn the practice lacks a standard protocol and may undermine weight-loss results.